Matthias Aizenberg

The U.S. Centers for Disease Control and Prevention has unexpectedly postponed the release of its annual abortion surveillance report, a critical federal document that has provided a national barometer of abortion trends for over half a century. This highly anticipated report, which was slated to

The biopharmaceutical sector is at a critical inflection point where groundbreaking scientific potential is met with unprecedented economic and regulatory pressures, reshaping the very definition of medical innovation. A convergence of advanced technologies, massive capital investments, and

For millions of people living with drug-resistant epilepsy, the hope for a cure often comes with a terrifying prospect: undergoing invasive brain surgery just to find the precise origin of their debilitating seizures. This high-stakes diagnostic journey requires surgeons to place electrodes

At the University of Southern California, a quiet revolution is underway, driven by visionary leadership and a historic philanthropic investment that is positioning the institution to fundamentally reshape how urologic cancers are diagnosed, treated, and potentially cured. Under the guidance of Dr.

In the relentless fight against aggressive brain cancers, where progress is often measured in small, hard-won increments, a major clinical trial has delivered a monumental leap forward for a specific group of patients facing a daunting diagnosis. The recently concluded STELLAR Phase 3 clinical

What if a hidden enemy within the body, silently damaging vital organs, could finally be dismantled with precision? For thousands battling rare diseases like AL amyloidosis, where toxic protein deposits wreak havoc on the heart and kidneys, this prospect is no longer a distant dream. A

Picture a high-stakes medical decision resting on the shoulders of a systematic review, the gold standard of evidence-based research, where every detail could impact patient lives. In this critical arena, artificial intelligence (AI), particularly large language models (LLMs), has emerged as a

What if a single batch of cells could save thousands of lives without the wait and expense of custom-made treatments? This isn’t a distant dream but a tangible reality unfolding in the realm of allogeneic cell therapy, where “off-the-shelf” solutions derived from donor cells are poised to

What if the key to beating the most common type of breast cancer lay hidden in the body's own defenses, waiting for science to unlock its potential? For the millions of women diagnosed with estrogen receptor-positive (ER-positive) breast cancer, which accounts for about 70% of all cases, a new

Imagine a future where a child’s medical treatment is as unique as their fingerprint, crafted precisely to match their genetic makeup, lifestyle, and environment, ensuring the best possible outcome with minimal side effects. This vision is no longer a distant dream but a tangible reality unfolding